| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 68.849 | 225.550 | 297.736 | 344.400 |
| Total Income - EUR | - | - | - | - | - | - | 68.986 | 227.260 | 297.809 | 344.470 |
| Total Expenses - EUR | - | - | - | - | - | - | 60.827 | 190.680 | 247.505 | 321.928 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | 8.159 | 36.580 | 50.304 | 22.542 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | 7.467 | 34.353 | 47.475 | 12.725 |
| Employees | - | - | - | - | - | - | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Farmacia Pharmavie S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 4.938 | 3.986 | 3.010 | 19.626 |
| Current Assets | - | - | - | - | - | - | 43.196 | 81.708 | 112.975 | 118.463 |
| Inventories | - | - | - | - | - | - | 25.961 | 38.644 | 52.619 | 53.650 |
| Receivables | - | - | - | - | - | - | 19.497 | 39.567 | 49.965 | 42.603 |
| Cash | - | - | - | - | - | - | -2.261 | 3.497 | 10.391 | 22.210 |
| Shareholders Funds | - | - | - | - | - | - | 7.122 | 41.497 | 53.687 | 66.112 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 41.012 | 44.197 | 62.297 | 71.977 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Farmacia Pharmavie S.r.l.